$NVGT Novagant Introduces GoldenCBD™ Edibles and
Post# of 250575
Posted On: 07/16/2014 7:10:57 AM
$NVGT Novagant Introduces GoldenCBD™ Edibles and Ingestable Products Line
Novagant Corp. (USOTC:NVGT)
Today : Wednesday 16 July 2014
DENVER, July 16, 2014 /PRNewswire/ -- Novagant Corp. (OTC: NVGT) (Pinksheets: NVGT) is pleased to announce that in this month of July it will release its GoldenCBD™ oil that will be available in several forms, including capsules and liquids. It will be the answer for those Medical Cannabis Patients living outside Washington and Colorado.
Novagant's GoldenCBD™, along with its GLAVAPE™ product, is proud to be the finest, most consistent Cannabidiol (CBD)-rich hemp oil in the world. The Company combined the power of natural hemp with the gift from mother nature to scientifically formulated CBD-rich hemp oil.
GoldenCBD™ is 100% natural and derived from the federally-legal industrial hemp plant. The Company's unique hemp cultivars, combined with its proprietary technologies, produce the highest quality CBD-rich hemp oil in the world.
GoldenCBD" is a mark of quality ensuring the highest quality as it is lab tested multiple times during the manufacturing process, from seed to shelf. The Company tests for CBD content, other cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and quality.
The GoldenCBD™ is:
• A natural organic (non-synthetic), safe, and legal product.
• Non-psychoactive.
• 3%-20% CBD+ by volume.
• Decarboxylated and filtered.
• Made from Hemp Oil (Seed & Stalk).
• Is from non-GMO industrial hemp grown without pesticides, herbicides, or chemical fertilizers.
• Is stringently lab tested for quality.
• Is independently certified.
"GoldenCBD™ is an important food supplement that is in dire need for those living outside of Washington and Colorado." Said Michael Thornton, VP at Novagant.
Cannabidiol is looked to for its "potential as a treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders." (http://www.projectcbd.org/about/introducing-cbd/)
About Novagant Corp.
Novagant Corp. was incorporated in the state of Nevada on February 23, 1987 under the name of Kendrex Systems, Inc. The Company underwent several name changes, and ultimately on November 26, 2013 changed its name to Novagant, Inc. For more information about the Company, please visit http://www.novagant.com.
Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Contact:
Novagant Corp.
office@novagant.com
SOURCE Novagant Corp.
Copyright 2014 PR Newswire
Novagant Corp. (USOTC:NVGT)
Today : Wednesday 16 July 2014
DENVER, July 16, 2014 /PRNewswire/ -- Novagant Corp. (OTC: NVGT) (Pinksheets: NVGT) is pleased to announce that in this month of July it will release its GoldenCBD™ oil that will be available in several forms, including capsules and liquids. It will be the answer for those Medical Cannabis Patients living outside Washington and Colorado.
Novagant's GoldenCBD™, along with its GLAVAPE™ product, is proud to be the finest, most consistent Cannabidiol (CBD)-rich hemp oil in the world. The Company combined the power of natural hemp with the gift from mother nature to scientifically formulated CBD-rich hemp oil.
GoldenCBD™ is 100% natural and derived from the federally-legal industrial hemp plant. The Company's unique hemp cultivars, combined with its proprietary technologies, produce the highest quality CBD-rich hemp oil in the world.
GoldenCBD" is a mark of quality ensuring the highest quality as it is lab tested multiple times during the manufacturing process, from seed to shelf. The Company tests for CBD content, other cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and quality.
The GoldenCBD™ is:
• A natural organic (non-synthetic), safe, and legal product.
• Non-psychoactive.
• 3%-20% CBD+ by volume.
• Decarboxylated and filtered.
• Made from Hemp Oil (Seed & Stalk).
• Is from non-GMO industrial hemp grown without pesticides, herbicides, or chemical fertilizers.
• Is stringently lab tested for quality.
• Is independently certified.
"GoldenCBD™ is an important food supplement that is in dire need for those living outside of Washington and Colorado." Said Michael Thornton, VP at Novagant.
Cannabidiol is looked to for its "potential as a treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders." (http://www.projectcbd.org/about/introducing-cbd/)
About Novagant Corp.
Novagant Corp. was incorporated in the state of Nevada on February 23, 1987 under the name of Kendrex Systems, Inc. The Company underwent several name changes, and ultimately on November 26, 2013 changed its name to Novagant, Inc. For more information about the Company, please visit http://www.novagant.com.
Safe Harbor:
Statements in this press release may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company's future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company's affiliates that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained in this press release. The Company disclaims any obligation to update any statements in this press release.
Contact:
Novagant Corp.
office@novagant.com
SOURCE Novagant Corp.
Copyright 2014 PR Newswire
(0)
(0)
